Article
Immunopathology of American Cutaneous Leishmaniasis, modulation of MHC Class II gene products by keratinocytes before and after glucantine therapy
Registro en:
PIRMEZ, Claude et al. Immunopathology of american cutaneous leishmaniasis. Modulation of MHC class II gene products by Keratinocytes before and after glucantime therapy. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 85, n. 2, p. 203-209, Apr./June 1990.
0074-0276
1678-8060
Autor
Pirmez, Claude
Oliveira Neto, Manoel Paes
Grimaldi Jr., Gabriel
Savino, Wilson
Resumen
Epidermal changes from 32 cutaneous and 3 mucosal American leishmaniasis (ACL) active lesions were studied for HLA-DR, -DP expression, Lanerhans cells and lymphocyte infiltration. In addition to a DR and DQ positivity at the surface of the cells of the inflammatory infiltrate, a strong reaction for DR antigens was detected on keratinocytes. Hyperplasia of Langerhans cells was present in al cutaneous lesions and epidermis was infiltrated by T lymphocytes. When healed lesions of 14 of these subjects were re-biopsied 1 to 12 months after the end of pentavalent antimonial therapy, MHC class antigens could no longer be seen on keratinocytes. Our data represrn evidence for hhe reversibility of the abnormal HLA-DR expression by keratinocytes in ACL after Glucantime therapy or spontaneous scar formation, demonstrating that this expresion is restricted to the period of active lesions. The present findings can be regarded as an indirect evidence that keratinocytes may be involved in the immunopathology of ACL.